The aldose reductase inhibitor siteKADOR, P. F; KINOSHITA, J. H; SHARPLESS, N. E et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 109-113, issn 0026-0495, suppl. 1Conference Paper

KINETICS OF AN ORALLY ABSORBED ALDOSE REDUCTASE INHIBITOR, SORBINILFOULDS G; O'BRIEN MM; BIANCHINE JR et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 5; PP. 693-700; BIBL. 22 REF.Article

The effect of aldose reductase and its inhibition on sugar cataract formationKADOR, P. F; AKAGI, Y; KINOSHITA, J. H et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 15-19, issn 0026-0495, suppl. 1Conference Paper

Applicability of red blood cell sorbitol measurements to monitor the clinical activity of sorbinilPETERSON, M. J; PAGE, M. G; JUST, L. J et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 93-95, issn 0026-0495, suppl. 1Conference Paper

Clinical trials of sorbinil on nerve functionPFEIFER, M. A.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 78-82, issn 0026-0495, suppl. 1Conference Paper

The polyol pathway, sorbinil, and renal dysfunctionBEYER-MEARS, A.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 46-54, issn 0026-0495, suppl. 1Conference Paper

Aldose and aldehyde reductase in animal tissuesFLYNN, T. G.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 105-108, issn 0026-0495, suppl. 1Conference Paper

Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitorsRAKOWITZ, Dietmar; HENNIG, Barbara; NAGANO, Marietta et al.Archiv der Pharmazie (Weinheim). 2005, Vol 338, Num 9, pp 411-418, issn 0365-6233, 8 p.Article

Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucoseKARIHALOO, A. K; JOSHI, K; CHOPRA, J. S et al.Journal of neurochemistry. 1997, Vol 69, Num 5, pp 2011-2018, issn 0022-3042Article

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with SorbinilO'HARE, J. P; MORGAN, M. H; ALDEN, P et al.Diabetic medicine. 1988, Vol 5, Num 6, pp 537-542, issn 0742-3071Article

Effect of sorbinil on myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose levelsYOREK, M. A; DUNLAP, J. A; GINSBERG, B. H et al.Journal of neurochemistry. 1988, Vol 51, Num 2, pp 331-338, issn 0022-3042Article

Proceedings/Symposium on aldose reductase inhibition and late, complications of diabetes. International diabetes federation polyol pathway workshop, Madrid 23 September 1985WARD, J. D; BENFIELD, P. Ed.Drugs (Basel). 1986, Vol 32, issn 0012-6667, 55 p., suppl. 2Conference Proceedings

A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathyArchives of ophthalmology (1960). 1990, Vol 108, Num 9, pp 1234-1244, issn 0003-9950, 11 p.Article

The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrationsLORENZI, M; TOLEDO, S; BOSS, G. R et al.Diabetologia (Berlin). 1987, Vol 30, Num 4, pp 222-227, issn 0012-186XArticle

Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lensLI-AN YEH; RAFFORD, C. E; BEYER, T. A et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 4-9, issn 0026-0495, suppl. 1Conference Paper

In-vitro assessment of a hypersensitivity syndrome associated with sorbinilSPIELBERG, S. P; SHEAR, N. H; CANNON, M et al.Annals of internal medicine. 1991, Vol 114, Num 9, pp 720-724, issn 0003-4819Article

Diabetic neuropathies: current concepts in prevention and treatmentWARD, J. D.Drugs (Basel). 1986, Vol 32, Num 3, pp 279-289, issn 0012-6667Article

Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproatePOULSOM, R.Biochemical pharmacology. 1986, Vol 35, Num 17, pp 2955-2959, issn 0006-2952Article

Inhibition of aldose reductase from human retinaPOULSOM, R.Current eye research (Print). 1987, Vol 6, Num 3, pp 427-432, issn 0271-3683Article

Studies of sorbinil on axonal transport in streptozotocin-diabetic ratsWILLARS, G. B; TOMLINSON, D. R; ROBINSON, J. P et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 66-70, issn 0026-0495, suppl. 1Conference Paper

Pathogenesis of diabetic neuropathy: do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?COLCIAGO, A; NEGRI-CESI, P; CELOTTI, F et al.Experimental and clinical endocrinology & diabetes. 2002, Vol 110, Num 1, pp 22-26, issn 0947-7349Article

Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitusCHRISTEN, W. G; MANSON, J. E; BUBES, V et al.American journal of epidemiology. 1999, Vol 150, Num 11, pp 1142-1151, issn 0002-9262Article

A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetesEATON, R. P; SIBBITT, W. L; SHAH, V. O et al.Journal of diabetes and its complications. 1998, Vol 12, Num 1, pp 34-38, issn 1056-8727Article

Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic ratsKÖRNER, A; CELSI, G; EKLÖF, A.-C et al.Diabetologia (Berlin). 1992, Vol 35, Num 5, pp 414-418, issn 0012-186XArticle

Concurrent increases in regional hematocrit and blood flow in diabetic rats : prevention by sorbinilSUTERA, S. P; CHANG, K; MARVEL, J et al.American journal of physiology. Heart and circulatory physiology. 1992, Vol 32, Num 3, pp H945-H950, issn 0363-6135Article